# Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization

**Authors:** Muhammad Sarfraz, Gautam Behl, Sweta Rani, Niall O'Reilly, Peter McLoughlin, Orla O'Donovan, Alison L. Reynolds, John Lynch, Laurence Fitzhenry

PMC · DOI: 10.1039/d5na90032h · 2025-05-02

## TL;DR

This paper corrects a previously published study on a nanoparticle system designed to improve dexamethasone delivery to the eye.

## Contribution

The correction addresses errors in the original publication to ensure accuracy and clarity.

## Key findings

- The correction clarifies data and methodology in the original study.
- It ensures the reliability of the twin nanoparticulate system's characterization and optimization.

## Abstract

Correction for ‘Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization’ by Muhammad Sarfraz et al., Nanoscale Adv., 2025, https://doi.org/10.1039/d4na01086h.

## Linked entities

- **Chemicals:** dexamethasone (PubChem CID 5743)

## Full-text entities

- **Chemicals:** dexamethasone (MESH:D003907)

---
Source: https://tomesphere.com/paper/PMC12046346